# Sagimet Biosciences Inc.: Form 8-K, filed Aug 16, 2024

- Company: [Sagimet Biosciences Inc.](/companies/sgmt.md) (CIK 1400118)
- Form: 8-K
- Filed: 2024-08-16
- Accepted by EDGAR: Aug 16, 2024, 20:53 ET
- Period: 2024-08-15
- Accession: 0001104659-24-090546
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1400118/000110465924090546/tm2421627d3_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1400118/000110465924090546/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1400118/000110465924090546/tm2421627d3_8k.htm

Filed Aug 16, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-090546. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.
